Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4Escherichia coliclonal complex-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4Escherichia coliclonal complex

Published:2016-07-07 Issue:11 Volume:71 Page:3072-3080
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Dufour Nicolas,Clermont Olivier,La Combe Béatrice,Messika Jonathan,Dion Sara,Khanna Varun,Denamur Erick,Ricard Jean-Damien,Debarbieux Laurent

Funder

Institut Pasteur and Assistance Publique–Hôpitaux de Paris

Programme Transversal de Recherche

Poste d′Accueil pour praticien hospitalier

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/11/3072/16863860/dkw253.pdf

Reference66 articles.

1. The population genetics of commensal Escherichia coli

2. Escherichia coli ST131, an Intriguing Clonal Group

3. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

4. Proposal for a New Inclusive Designation for Extraintestinal Pathogenic Isolates ofEscherichia coli:ExPEC

5. The link between phylogeny and virulence in Escherichia coli extraintestinal infection;Picard;Infect Immun,1999

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections;Clinical Microbiology Reviews;2024-09-12

2. Phage therapy: an alternative treatment modality for MDR bacterial infections;Infectious Diseases;2024-07-17

3. Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance;Frontiers in Microbiology;2024-07-05

4. Between Centralization and Fragmentation: The Past, Present, and Future of Phage Collections;PHAGE;2024-03-01

5. The rise, fall, and resurgence of phage therapy for urinary tract infection;EcoSal Plus;2024-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3